Broadband Light for Age Spots
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you must stop taking your current medications. However, you cannot participate if you are taking prescription anticoagulation medications, immunosuppressive medications, or medications that increase sensitivity to light. Also, you must not have used systemic retinoids or corticosteroids within 6 months, or topical retinoids, corticosteroids, or hydroquinone on the target area within 1 month before the study.
What data supports the idea that Broadband Light for Age Spots is an effective treatment?
The available research shows that Broadband Light, also known as Intense Pulsed Light (IPL), is effective for treating age spots. One study highlights its use for improving skin affected by sun exposure, which includes age spots. Another study mentions its success in treating skin damage and rejuvenating the skin. While the research primarily focuses on skin rejuvenation, the positive outcomes for sun-related skin issues suggest that IPL is a promising option for age spots.12345
What safety data exists for Broadband Light treatment for age spots?
Broadband Light, also known as Intense Pulsed Light (IPL), is generally regarded as a safe treatment for skin rejuvenation and age spots. Studies have shown that IPL is effective for various skin types, including darker skin, and can improve conditions like dyspigmentation and skin texture without significant adverse effects. However, there are risks, such as vesiculobullous eruptions, though these are not common. Safety can be enhanced by adjusting treatment settings based on individual skin types and conditions. No serious adverse events were recorded in studies involving a range of skin treatments, indicating a favorable safety profile when used appropriately.26789
Is Broadband Light a promising treatment for age spots?
What is the purpose of this trial?
Broadband light treatment for Solar Lentigines
Research Team
Jonathan Cook, MD
Principal Investigator
Sanctuary Plastic Surgery
Eligibility Criteria
This trial is for healthy adults over 18 with moderate to severe skin pigmentation who are not pregnant, don't plan to be during the study, and agree to limited sun exposure and using SPF 50 sunscreen. Excluded are those with certain skin conditions, recent cosmetic treatments in the area, or increased light sensitivity due to medications.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Broadband light treatment for Solar Lentigines
Follow-up
Participants are monitored for histological changes in skin post treatment
Treatment Details
Interventions
- Broadband Light
Broadband Light is already approved in United States, European Union, Canada for the following indications:
- Solar Lentigines
- Rosacea
- Acne
- Fine Lines
- Wrinkles
- Skin Texture Improvement
- Sun Damage
- Age Spots
- Hyperpigmentation
- Solar Lentigines
- Rosacea
- Acne
- Fine Lines
- Wrinkles
- Skin Texture Improvement
- Sun Damage
- Age Spots
- Hyperpigmentation
- Solar Lentigines
- Rosacea
- Acne
- Fine Lines
- Wrinkles
- Skin Texture Improvement
- Sun Damage
- Age Spots
- Hyperpigmentation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sciton
Lead Sponsor